B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ACR Poster Session A<br />
609. Mice Lacking the Receptor-Like Protein Tyrosine Phosphatase<br />
CD148 Are Protected from Bleomycin-Induced Pulmonary<br />
Fibrosis. Tamiko R. Katsumoto 1 , Kevin K. Kim 2 , Alexis N.<br />
Brumwell 2 , John X. Nguyen 2 , Jing W. Zhu 2 , Mark R. Looney 2 ,<br />
Harold A. Chapman 2 and Arthur Weiss 2 , 1 UCSF, South San<br />
Francisco, CA, 2 UCSF.<br />
610. Noggin +/LacZ Heterozygous Mice Have Reduced Pulmonary<br />
Fibrosis in the Bleomycin Induced Model. Ellen de Langhe 2 ,<br />
Vanessa De Vooght 2 , Frank P. Luyten 1 and Rik Lories 1 , 1 KU<br />
Leuven, Leuven, Belgium, 2 KU Leuven.<br />
611. Nr4a1 Ameliorates the Pro-Fibrotic Effects <strong>of</strong> TGFβ in Systemic<br />
Sclerosis (SSc) and Might Be an Interesting Target for Anti-<br />
Fibrotic Therapies. Katrin Palumbo 1 , Alfiya Akhmetshina 1 ,<br />
Pawel Zerr 1 , Michal Tomcik 1 , Angelika Horn 1 , Clara Dees 1 , Oliver<br />
Distler 3 , Georg Schett 2 and Jorg H. W. Distler 4 , 1 Department<br />
<strong>of</strong> Internal Medicine III and Institute for Clinical Immunology,<br />
University <strong>of</strong> Erlangen-Nuremberg, Erlangen, Germany,<br />
2<br />
Friedrich Alexander Univ, Erlangen, Germany, 3 University<br />
Hospital Zurich, Zurich, Switzerland, 4 University <strong>of</strong> Erlangen,<br />
Erlangen, Germany.<br />
612. Osteopontin in Systemic Sclerosis and Its Role in Dermal<br />
Fibrosis. Minghua Wu 2 , Daniel J. Schneider 1 , Maureen D.<br />
Mayes 3 , Shervin Assassi 2 , Frank C. Arnett 4 , Filemon K. Tan 5 ,<br />
Michael R. Blackburn 1 and Sandeep K. Agarwal 2 , 1 Department<br />
<strong>of</strong> Biochemistry and Molecular Biology, UTHSC-H, Houston,<br />
TX, 2 Division <strong>of</strong> <strong>Rheumatology</strong> and Clinical Immunogenetics,<br />
University <strong>of</strong> Texas Health Science Center at Houston, Houston,<br />
TX, 3 University <strong>of</strong> Texas-Houston, Houston, TX, 4 UT Medical<br />
School, Houston, TX, 5 UT-Houston Med School, Houston, TX.<br />
613. Relevance <strong>of</strong> Epithelial Phenotypic Switching in the<br />
Pathogenesis <strong>of</strong> Systemic Sclerosis. Xu Shiwen 1 , S. Sonnylal 3 ,<br />
A. Tam 2 , R. Stratton 2 , A. Leask 2 , C. P. Denton 2 , J. Norman 2<br />
and D. Abraham 2 , 1 <strong>Rheumatology</strong>, London, United Kingdom,<br />
2<br />
<strong>Rheumatology</strong>,, United Kingdom, 3 UT M. D. Anderson Cancer,<br />
Houston, TX.<br />
614. S100A4 as a Novel Mediator <strong>of</strong> TGF-β Driven Dermal Fibrosis<br />
in Systemic Sclerosis. Michal Tomcik 4 , Pawel Zerr 2 , Katrin<br />
Palumbo 2 , Barbara G. Fürnrohr 2 , Jerome Avouac 3 , Angelika<br />
Horn 2 , Clara Dees 2 , Alfiya Akhmetshina 2 , Christian Beyer 2 ,<br />
Radim Becvar 7 , Oliver Distler 1 , Mariam Grigorian 6 , Ladislav<br />
Senolt 7 , Georg Schett 5 and Jorg H. W. Distler 8 , 1 Center <strong>of</strong><br />
Experimental <strong>Rheumatology</strong> and Zurich Center <strong>of</strong> Integrative<br />
Human Physiology, University Hospital Zurich, Switzerland,<br />
2<br />
Department <strong>of</strong> Internal Medicine III and Institute for<br />
Clinical Immunology, University <strong>of</strong> Erlangen-Nuremberg,<br />
Erlangen, Germany, 3 Department <strong>of</strong> Internal Medicine III<br />
and Institute for Clinical Immunology, University <strong>of</strong> Erlangen-<br />
Nuremberg, Erlangen, Germany and Paris Descartes University,<br />
<strong>Rheumatology</strong> A Department Cochin Hospital, Paris, France,<br />
4<br />
Department <strong>of</strong> Internal Medicine III, University <strong>of</strong> Erlangen-<br />
Nuremberg, Erlangen, Germany and Institute <strong>of</strong> <strong>Rheumatology</strong><br />
and Connective Tissue Research Laboratory, Department<br />
<strong>of</strong> <strong>Rheumatology</strong> <strong>of</strong> the First Faculty <strong>of</strong> Medicine, Charles<br />
University i, 5 Friedrich Alexander Univ, Erlangen, Germany,<br />
6<br />
Institute <strong>of</strong> Cancer Biology, Danish Cancer Society, Copenhagen,<br />
Denmark, 7 Institute <strong>of</strong> <strong>Rheumatology</strong> and Connective Tissue<br />
Research Laboratory, Department <strong>of</strong> <strong>Rheumatology</strong> <strong>of</strong> the<br />
First Faculty <strong>of</strong> Medicine, Charles University in Prague, Czech<br />
Republic, 8 University <strong>of</strong> Erlangen, Erlangen, Germany.<br />
615. The Synthetic Cannabinoid Ajulemic Acid Targets<br />
Scleroderma Fibrosis. Estrella Garcia Gonzalez 3 , Enrico Selvi 2 ,<br />
Balistreri Epifania 3 , Alfiya Akhmetshina 1 , Sauro Lorenzini 3 ,<br />
Kathrin Palumbo 1 , Mauro Galeazzi 3 and Jorg W. H. Distler 1 ,<br />
1<br />
Departement <strong>of</strong> Internal Medicine III and Institute for Clinical<br />
Immunology -Friedrich-Alexander University-Erlangen-Germany,<br />
2<br />
<strong>Rheumatology</strong> Unit - Departement <strong>of</strong> Clinical Medicine and<br />
Immunological Sciences-University <strong>of</strong> Siena, Siena, Italy,<br />
3<br />
<strong>Rheumatology</strong> Unit - Departement <strong>of</strong> Clinical Medicine and<br />
Immunological Sciences-University <strong>of</strong> Siena- Italy.<br />
616. The Transcription Factor AP-1 Mediates the Pro-Fibrotic Effects<br />
<strong>of</strong> TGFβ and Contributes to the Development <strong>of</strong> Experimental<br />
Dermal Fibrosis. Jerome Avouac 3 , Katrin Palumbo 2 , Michal<br />
Tomcik 4 , Pawel Zerr 2 , Clara Dees 2 , Angelika Horn 2 , Alfiya<br />
Akhmetshina 2 , Christian Beyer 2 , Shunichi Shiozawa 5 , Oliver<br />
Distler 1 , Georg Schett 6 , Yannick Allanore 7 and Jorg H. W. Distler 8 ,<br />
1<br />
Center <strong>of</strong> Experimental <strong>Rheumatology</strong> and Zurich Center <strong>of</strong><br />
Integrative Human Physiology, University Hospital Zurich, Zurich,<br />
Switzerland, 2 Department <strong>of</strong> Internal Medicine III and Institute<br />
for Clinical Immunology, University <strong>of</strong> Erlangen-Nuremberg,<br />
Erlangen, Germany, 3 Department <strong>of</strong> Internal Medicine III<br />
and Institute for Clinical Immunology, University <strong>of</strong> Erlangen-<br />
Nuremberg, Erlangen, Germany, Paris Descartes University,<br />
<strong>Rheumatology</strong> A Department, Cochin Hospital and INSERM U 781 ,<br />
Necker Hospital, Paris, Fra, 4 Department <strong>of</strong> Internal Medicine<br />
III, University <strong>of</strong> Erlangen-Nuremberg, Erlangen, Germany and<br />
Institute <strong>of</strong> <strong>Rheumatology</strong> and Connective Tissue Research<br />
Laboratory, Department <strong>of</strong> <strong>Rheumatology</strong> <strong>of</strong> the First Faculty<br />
<strong>of</strong> Medicine, Charles University i, 5 Division <strong>of</strong> <strong>Rheumatology</strong>,<br />
Department <strong>of</strong> Medicine, Kobe University Graduate School <strong>of</strong><br />
Medicine, Kobe University Hospital, Kobe, Japan, 6 Friedrich<br />
Alexander Univ, Erlangen, Germany, 7 Paris Descartes University,<br />
<strong>Rheumatology</strong> A Department, Cochin Hospital and INSERM<br />
U781, Necker Hospital, Paris, France, 8 University <strong>of</strong> Erlangen,<br />
Erlangen, Germany.<br />
617. The Triterpenoid CDDO Abrogates Canonical TGF-beta<br />
Signaling and Fibrotic Responses in Normal and Scleroderma<br />
Fibroblasts by Stabilizing the Anti-Oxidant Nuclear Factor-<br />
Like 2 (Nrf2). Kazuhiro Komura 2 , Jun Wei 2 , Gabriel Lord 2 and<br />
John Varga 1 , 1 Northwestern Univ Feinberg School, Chicago, IL,<br />
2<br />
Northwestern University Feinberg School <strong>of</strong> Medicine.<br />
618. Urantide Prevents and Alleviates Monocrotaline Induced<br />
Pulmonary Arterial Hypertension in Wistar Rats. Yifang<br />
Mei 1 , Hong Jin 3 , Hao Wang 2 , Wei Tian 2 , Yanping Zhao 2 and<br />
Zhiyi Zhang 2 , 1 The First Affiliated Hospital <strong>of</strong> Harbin Medical<br />
University, Harbin, Heilongjiang, China, 2 The First Affiliated<br />
Hospital <strong>of</strong> Harbin Medical University, Harbin, China, 3 The<br />
First Affiliated Hospital <strong>of</strong> Shantou University Medical <strong>College</strong>,<br />
Shantou, China.<br />
619. Visfatin/NAMPT in Interstitial Pneumonia <strong>of</strong> Patients with<br />
Systemic Sclerosis and Scleroderma Mice Model Induced<br />
by Bleomycin. Hirahito Endo 2 , Tatsuhiro Yamamoto 1 , Kaichi<br />
Kaneko 3 , Yoshie Kusunoki 3 , Natsuko Kusunoki 3 and Shinichi<br />
Kawai 3 , 1 Division <strong>of</strong> <strong>Rheumatology</strong>, Department <strong>of</strong> Internal<br />
Medicine, Toho University School <strong>of</strong> Medicine, Ohmori-nishi,<br />
Ohta-ku, Japan, 2 Division <strong>of</strong> <strong>Rheumatology</strong>, Department <strong>of</strong><br />
Internal Medicine, Toho University School <strong>of</strong> Medicine, Ohmorinishi,<br />
Oh-taku, Japan, 3 Division <strong>of</strong> <strong>Rheumatology</strong>, Department <strong>of</strong><br />
Internal Medicine, Toho University School <strong>of</strong> Medicine.<br />
190<br />
2010 Program Book